Endocrinology Archives - Page 2 of 9

Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases

Enrique Casado, Ester Costa, Pedro Mezquita-Raya, Rubén Andújar-Espinosa, José Luis Neyro

Article Type

Review

Published

06 Sep 2023

In this review, the authors examine evidence that implicates vitamin D deficiency in diverse conditions in the clinical settings of endocrinology, rheumatology, pneumology and reproductive health.

Tirzepatide for type 2 diabetes

Sarah L Anderson, Joel C Marrs

Article Type

Review

Published

22 Aug 2023

This narrative review intends to list and discuss the glycaemic efficacy, key safety and weight loss outcomes related to the treatment of Type 2 diabetes with tirzepatide.

Descriptive study of a clinical and educational telemedicine intervention in patients with diabetes receiving glargine 300U/ml (Toujeo) in Spain: results of the T-Coach programme

Virginia Bellido, Cristóbal Morales, Araceli Muñoz Garach, José Manuel García Almeida, Juan Luis Fernández Morera, Beatriz González Aguilera, Martín López de la Torre, Diego Bellido

Article Type

Original Research

Published

24 May 2023

This article analyzes the data collected from the T-Coach patient support programme and evaluates the effect of the programme in terms of treatment satisfaction, adherence and effect on disease knowledge. 6-month results are present here.

Corrigendum: Diabetes: how to manage chronic kidney disease

Jennifer N Clements

Article Type

Corrigendum

Published

21 Jul 2022

The authors wish to make the following corrections to their article: Clements JN. Diabetes: how to manage chronic kidney disease. Drugs Context. 2022;11:2021-9-10. https://doi.org/10.7573/dic.2021-9-10

Diabetes: how to manage cardiovascular risk in secondary prevention patients

Sarah L Anderson, Joel C Marrs

Article Type

Review

Published

14 Jun 2022

This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.